Filed: 8/14/2024ACC: 0000919574-24-004535
📋 What this filing means
CAXTON CORP filed this quarterly 13F‑HR report disclosing 12 equity positions with a total reported market value of $19.73M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
12
Positions
$19.73M
Total AUM (reported)
6.74M
Total Shares
Allocation by class
COM$12.07M61.1%
COM NEW$6.05M30.7%
TR UNIT$1.02M5.2%
CL B NEW$417.1K2.1%
SPONSORED ADS$183.8K0.9%
Portfolio Concentration
Top 3$18.19M92.2%
4–10$1.48M7.5%
11–25$58.1K0.3%
Top 3 weight
92.2%
Top 10 weight
99.7%
Voting Authority Distribution
Total shares with voting rights: 6.74M
Sole
Full voting authority
6.74M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole12
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings12
Rows:
XERIS BIOPHARMA HOLDINGS INC
SOLEShares5.11M
TypeSH
Market value$11.51M
58.31%
Sole
5.11M
Shared
0.00
None
0.00
REZOLUTE INC
SOLEShares1.32M
TypeSH
Market value$5.67M
28.74%
Sole
1.32M
Shared
0.00
None
0.00
SPDR S&P 500 ETF TR
SOLEShares1.87K
TypeSH
Market value$1.02M
5.15%
Sole
1.87K
Shared
0.00
None
0.00
BERKSHIRE HATHAWAY INC DEL
SOLEShares1.02K
TypeSH
Market value$417.1K
2.11%
Sole
1.02K
Shared
0.00
None
0.00
LEXEO THERAPEUTICS INC
SOLEShares17.85K
TypeSH
Market value$286.3K
1.45%
Sole
17.85K
Shared
0.00
None
0.00
MIND MEDICINE INC
SOLEShares30.38K
TypeSH
Market value$219.1K
1.11%
Sole
30.38K
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares13.90K
TypeSH
Market value$183.8K
0.93%
Sole
13.90K
Shared
0.00
None
0.00
KYVERNA THERAPEUTICS INC
SOLEShares22.98K
TypeSH
Market value$172.4K
0.87%
Sole
22.98K
Shared
0.00
None
0.00
MOLECULAR TEMPLATES INC
SOLEShares136.87K
TypeSH
Market value$157.4K
0.80%
Sole
136.87K
Shared
0.00
None
0.00
COMPASS THERAPEUTICS INC
SOLEShares43.47K
TypeSH
Market value$43.5K
0.22%
Sole
43.47K
Shared
0.00
None
0.00
CONTEXT THERAPEUTICS INC
SOLEShares18.40K
TypeSH
Market value$36.9K
0.19%
Sole
18.40K
Shared
0.00
None
0.00
ADICET BIO INC
SOLEShares17.49K
TypeSH
Market value$21.2K
0.11%
Sole
17.49K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
XERIS BIOPHARMA HOLDINGS INCSOLE | COM | 5.11M | SH | $11.51M 58.31% | 5.11M | 0.00 | 0.00 |
REZOLUTE INCSOLE | COM NEW | 1.32M | SH | $5.67M 28.74% | 1.32M | 0.00 | 0.00 |
SPDR S&P 500 ETF TRSOLE | TR UNIT | 1.87K | SH | $1.02M 5.15% | 1.87K | 0.00 | 0.00 |
BERKSHIRE HATHAWAY INC DELSOLE | CL B NEW | 1.02K | SH | $417.1K 2.11% | 1.02K | 0.00 | 0.00 |
LEXEO THERAPEUTICS INCSOLE | COM | 17.85K | SH | $286.3K 1.45% | 17.85K | 0.00 | 0.00 |
MIND MEDICINE INCSOLE | COM NEW | 30.38K | SH | $219.1K 1.11% | 30.38K | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 13.90K | SH | $183.8K 0.93% | 13.90K | 0.00 | 0.00 |
KYVERNA THERAPEUTICS INCSOLE | COM | 22.98K | SH | $172.4K 0.87% | 22.98K | 0.00 | 0.00 |
MOLECULAR TEMPLATES INCSOLE | COM NEW | 136.87K | SH | $157.4K 0.80% | 136.87K | 0.00 | 0.00 |
COMPASS THERAPEUTICS INCSOLE | COM | 43.47K | SH | $43.5K 0.22% | 43.47K | 0.00 | 0.00 |
CONTEXT THERAPEUTICS INCSOLE | COM | 18.40K | SH | $36.9K 0.19% | 18.40K | 0.00 | 0.00 |
ADICET BIO INCSOLE | COM | 17.49K | SH | $21.2K 0.11% | 17.49K | 0.00 | 0.00 |